Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adriamycin-induced cardiomyopathy. A rat model.

A Czarnecki, A Hinek, D Sołtysiak-Pawluczuk

    Polish Journal of Pharmacology and Pharmacy
    |March 1, 1986
    PubMed
    Summary

    A rat model of adriamycin-induced cardiomyopathy was developed. The 25 mg/kg dose of adriamycin (ADR) is recommended for future studies on limiting ADR cardiotoxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Time Reversal Violating Effects: R-Correlation Measurement in Neutron Decay.

    Journal of research of the National Institute of Standards and Technology·2016
    Same author

    β-pompilidotoxin modulates spontaneous activity and persistent sodium currents in spinal networks.

    Neuroscience·2010
    Same author

    A novel fibrotic disorder associated with increased dermal fibroblast proliferation and downregulation of genes of the microfibrillar network.

    The British journal of dermatology·2010
    Same author

    Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.

    Neuropathology and applied neurobiology·2007
    Same author

    Estimate of B(B(over) -->Xgamma) at O(alpha(s)2).

    Physical review letters·2007
    Same author

    Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest.

    Anticancer research·2006

    Area of Science:

    • Cardiovascular research
    • Toxicology
    • Animal models

    Background:

    • Adriamycin (ADR) is a widely used chemotherapy agent.
    • ADR is known to cause cardiotoxicity.
    • Developing reliable animal models is crucial for studying ADR toxicity.

    Purpose of the Study:

    • To establish a rat model of adriamycin-induced cardiomyopathy.
    • To evaluate the dose-dependent effects of ADR on cardiac function and overall health.
    • To identify a suitable ADR dosage for future research on mitigating cardiotoxicity.

    Main Methods:

    • Rats were injected with ADR at total doses of 21, 25, and 30 mg/kg in 15 equal partial doses.
    • Evaluated parameters included body weight, hematocrit, white blood cell count, SGOT activity, ECG, and histopathological examination of heart tissue.
    • Histopathological analysis was performed on heart samples.

    Main Results:

    • ADR administration resulted in weight loss, decreased hematocrit, leucopenia, elevated SGOT, and ECG changes.
    • Cardiomyopathic changes were observed in heart tissues of rats treated with 25 and 30 mg/kg ADR.
    • The 25 mg/kg ADR dose demonstrated significant cardiotoxic effects.

    Conclusions:

    • A reproducible rat model for adriamycin-induced cardiomyopathy was successfully established.
    • The 25 mg/kg ADR dose is proposed as an optimal dose for further investigations into ADR cardiotoxicity.
    • This model can aid in developing strategies to limit adriamycin toxicity in cancer therapy.

    Related Experiment Videos